DNMT3B and breast carcinoma: In contrast, knockdown of miR-148b, miR-26b, or miR-29c in non-hypermethylated breast cancer cell lines (MDA-MB-468, MDA-MB-415, and BT20) showed increased DNMT3b mRNA levels [40].